TMO vs ZVRA · P/E 24, rev $23.00B vs P/E 6.3, rev $75.9M
Thermo Fisher Scientific Inc (TMO) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US. It is led by Marc N. Casper.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the TMO and ZVRA stock pages for the full models.
Not investment advice.